https://regulatorynews.com/argus-cognitive-neurora-fda-clearance Regulatory News en 2026-10-10T09:40:14-04:00 Argus Cognitive Earns FDA Clearance for Neurora https://regulatorynews.com/medical-microinstruments-symani-series-d-financing Regulatory News en 2026-10-10T09:40:14-04:00 Medical Microinstruments Lands $125M for Symani https://regulatorynews.com/vir-biotechnology-vir-5500-fast-track-designation Regulatory News en 2026-10-10T09:40:14-04:00 Vir Biotechnology Wins FDA Fast Track for VIR-5500 https://regulatorynews.com/ema-pre-cta-pilot-permanent Regulatory News en 2026-10-10T06:03:25-04:00 EMA Makes Pre-CTA Trial Advice Pilot Permanent https://regulatorynews.com/fda-biosimilar-manufacturing-changes-guidance-final Regulatory News en 2026-10-10T06:03:25-04:00 FDA Finalizes Biosimilar Manufacturing-Change Rules https://regulatorynews.com/par-health-brevital-sodium-recall Regulatory News en 2026-10-10T06:03:25-04:00 Par Health Recalls Brevital Sodium Over Cellulose https://regulatorynews.com/tecentriq-adjuvant-dmmr-colon-cancer-approval Regulatory News en 2026-10-09T10:57:15-04:00 FDA Approves First Adjuvant Immunotherapy for Colon Cancer https://regulatorynews.com/lipocine-verity-tlando-health-canada-approval Regulatory News en 2026-10-09T09:43:18-04:00 Lipocine, Verity Win Health Canada Nod for TLANDO https://regulatorynews.com/perspective-therapeutics-psv359-fast-track-designation Regulatory News en 2026-10-09T09:43:18-04:00 Perspective Wins FDA Fast Track for PSV359 in Rare Sarcoma https://regulatorynews.com/zenflow-spring-series-d-cook-medical Regulatory News en 2026-10-09T09:43:18-04:00 Zenflow Lands $52M Series D, Cook Medical Distribution https://regulatorynews.com/fda-hyperoxia-monitoring-device-classification Regulatory News en 2026-10-09T06:02:53-04:00 FDA Finalizes Class II Rule for Hyperoxia Monitors https://regulatorynews.com/fda-toxicology-test-systems-510k-exemption Regulatory News en 2026-10-09T06:02:53-04:00 FDA Eases 510(k) Rule for Federal Drug-Test Devices https://regulatorynews.com/fda-tucatinib-maintenance-her2-breast-cancer Regulatory News en 2026-10-09T06:02:53-04:00 FDA Approves Tucatinib Maintenance for HER2+ Cancer